Tibet Pharma Investors Ask Court To Dismiss IPO Suits
Investors in a Tibetan pharmaceutical company that accused it of lying about its financial health ahead of a 2011 initial public offering told a New Jersey court Thursday that they had...To view the full article, register now.
Already a subscriber? Click here to view full article